AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Share Issue/Capital Change Mar 20, 2020

7581_rns_2020-03-20_0788956c-5984-478d-be07-a5548733a6be.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9714G

Craneware plc

20 March 2020

Craneware plc

("Craneware" or the "Company")

Blocklisting Application

Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that a block listing application has been made to the London Stock Exchange for 350,000 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission").  The Ordinary Shares that are being reserved under this block listing application will be issued by the Company, as required, in order to satisfy the exercise of share options and vested awards pursuant to the terms of the following share plans:

Share plan Number of Ordinary Shares
The Craneware plc Schedule 4 Company Share Option Plan (2016) 50,000
The Craneware plc Unapproved Company Share Option Plan (2016) 200,000
The Craneware plc Long Term Incentive Plan (2016) 100,000
Total 350,000

It is expected that Admission of these Ordinary Shares will become effective on 23 March 2020. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.

For further information, please contact:

Craneware plc Peel Hunt Investec Bank Alma
(NOMAD & Joint Broker) (Joint Broker) (Financial PR)
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)20 7597 5970 +44 (0)203 405 0205
Keith Neilson, CEO Dan Webster Patrick Robb Caroline Forde
Craig Preston, CFO George Sellar Sebastian Lawrence Hilary Buchanan
Andrew Clark Henry Reast Helena Bogle

About Craneware

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

Learn more at www.craneware.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSPPUWAWUPUUMU

Talk to a Data Expert

Have a question? We'll get back to you promptly.